Primary cutaneous infection by Aspergillus ustus in a 62-year-old liver transplant recipient.
We report the first case of primary cutaneous aspergillosis caused by Aspergillus ustus, a species that seldom infects human beings. The patient, a 62-year-old liver transplant recipient with end-stage hepatitis C-induced cirrhosis, was receiving the experimental immunosuppressive drug FK-506. Trauma to the skin of the right arm from tape and from an arm board holding intravenous and intraarterial catheters in place and to the left leg from an occlusive knee brace may have contributed to this unusual mycosis. The patient's cutaneous aspergillosis responded to a combination of intravenous amphotericin B and topical terbinafine cream. Although the patient died shortly thereafter from hepatic failure, there was no evidence of systemic aspergillosis.
Department of Dermatology, Harvard University, Boston, MA.
M J
MJ
Stiller
L
L
Teperman
S A
SA
Rosenthal
A
A
Riordan
J
J
Potter
J L
JL
Shupack
M A
MA
Gordon
D001228:Aspergillosis / Q000188:drug therapy / Q000209:etiology / Q000382:microbiology*; D001230:Aspergillus / Q000302:isolation & purification; D003428:Cross Infection / Q000209:etiology; D003881:Dermatomycoses / Q000188:drug therapy / Q000209:etiology / Q000382:microbiology*; D006801:Humans; D016031:Liver Transplantation; D008297:Male; D008875:Middle Aged; D009894:Opportunistic Infections / Q000188:drug therapy / Q000209:etiology / Q000382:microbiology; D012307:Risk Factors